Stem cells and vascular regenerative medicine: A mini review

Archive ouverte

Stoltz, Jean-François | Bensoussan, Danièle | de Isla, Natalia | Zhang, L. | Han, Z. | Magdalou, Jacques | Huselstein, C. | Ye, J.S. | Leballe, B. | Decot, Véronique | Reppel, Loic

Edité par CCSD ; IOS Press -

International audience. Most human tissues do not regenerate spontaneously, which is why "cell therapy" are promising alternative treatments. The Principe is simple: patients' or donors' cells are collected and introduced into the injured tissues or organs directly or in a porous 3D material, with or without modification of their properties. This concept of regenerative medicine is an emerging field which can be defined as "the way to improve health and quality of life by restoring, maintaining, or enhancing tissue and organ functions".There is an extraordinarily wide range of opportunities for clinical applications: artheropathies, diabetes, cartilage defects, bone repair, burns, livers or bladder regeneration, organs reconstruction (lung, heart, liver...) neurodegenerative disorders, sepsis...Different stem cells (SC) with different potential can be used and characterised (totipotent, mesenchymal of different origins, especially those present in tissues...). Today it is undeniable that cells like bone marrow, adipose tissue or Wharton Jelly stem cells, are of potential interest for clinical applications because they are easily separated and prepared and no ethical problems are involved in their use.In this paper some potential clinical applications in the vascular field are considered: peripheral arteriopathy in diabetic patients, cardiac insufficiency, traitment of erectile dysfunction, or organ regeneration with liver as example. But the regeneration of tissue or organ is and will remain a challenge for the future development of cell therapy. Many problems remain to be solved that could lead to the development of innovative strategies to facilitate cell differentiation, increase the yield of cells and ensure a standardised product, overcome the risks of teratogenic effects and/or immune reactions, enable grafting via direct cell or biotissue transplantation and avoid legal issues involved in national regulations.

Consulter en ligne

Suggestions

Du même auteur

Stem Cells and Regenerative Medicine. Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century

Archive ouverte | Stoltz, Jean-François | CCSD

International audience. Since the 1960s and the therapeutic use of hematopoietic stem cells of bone marrow origin, there has been an increasing interest in the study of undifferentiated progenitors that have the abi...

Stem Cells and Regenerative Medicine. Stem Cells and Regenerative Medicine: Proceedings of the 9th China-France Symposium on Stem Cells and Regenerative Medicine

Archive ouverte | George, Daniel | CCSD

International audience. Most human tissues do not regenerate spontaneously, but the development of biotherapies using stem cells may offer promising alternatives. Among the possible medium-term therapeutic applicati...

Validation of a single-platform method for hematopoietic CD34+stem cells enumeration according to accreditation procedure

Archive ouverte | Massin, Frédéric | CCSD

5th China-France International Symposium, Kunming, PEOPLES R CHINA, DEC 12-14, 2013. International audience. INTRODUCTION: Stem cells for autologous and allogenic transplantation are obtained from several sources in...

Chargement des enrichissements...